Advances in relationship between deacetylase (sirtuin) and aging

Progress in Biochemistry and Biophysics

Volumn 37, Issue 12, 2010, Pages 1271-1277

  Peng, Qi ^a   Chen, Wei Chun ^a   Liu, Xin Guang ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Aging; Deacetylase; NAD; Sirtuin

Indexed keywords

MAMMALIA;

EID: 79951900487     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2010.00241     Document Type: Review

References (51)

1. Finkel T, Deng C X, Mostoslavsky R. Recent progress in the biology and physiology of sirtuins. Nature, 2009, 460(7255): 587-591
2. Guarente L P, Partridge L, Cwallace D. Molecular Biology of Aging. New York: Cold Spring Harbor Laboratory Press, 2008: 49-56
3. Tsukamoto Y, Kato J, Ikeda H. Silencing factors participate in DNA repair and recombination in Saccharomyces cerevisiae. Nature, 1997, 388(6645): 900-903 (Pubitemid 27377065)
4. Avalos J L, Celic I, Muhammad S, et al. Structure of a Sir2 enzyme bound to an acetylated p53 peptide. Mol Cell, 2002, 10(3): 523-535 (Pubitemid 35291068)
5. Huhtiniemi T, Wittekindt C, Laitinen T, et al. Comparative and pharmacophore model for deacetylase SIRT1. J Comput Aided Mol Des, 2006, 20(9): 589-599 (Pubitemid 44823893)
6. Canto C, Auwerx J. Caloric restriction, SIRT1 and longevity. Trends Endocrinol Metab, 2009, 20(7): 325-331
7. + -dependent histone deacetylase SIRT1. J Biol Chem, 2007, 282(2): 6823-6832 (Pubitemid 47100909)
8. Michishita E, Park J Y, Burneskis J M, et al. Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins. Mol Biol Cell, 2005, 16(10): 4623-4635 (Pubitemid 41416446)
9. Mostoslavsky R, Chua K F, Lombard D B, et al. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell, 2006, 124(2): 315-329 (Pubitemid 43121980)
10. +-dependent histone deacetylase that translocates to the mitochondria upon cellular stress. Genes Dev, 2007, 21(8): 920-928 (Pubitemid 46625641)
11. + in the deacetylase activity of the SIR2-like proteins. Biochem Biophys Res Commun, 2000, 278(3): 685-690
12. Lombard D B. Sirtuins at the breaking point: SIRT6 in DNA repair. Aging(Albany NY). 2009, 1(1): 12-16
13. Marton O, Koltai E, Nyakas C, et al. Aging and exercise affect the level of protein acetylation and SIRT1 activityin cerebellum of male rats. Biogerontology, 2010, 11(6): 679-686
14. Imai S, Guarente L. Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci, 2010, 31(5): 212-220
15. Tang B L, Chua C E. Is systemic activation of Sirt1 beneficial for ageing-associated metabolic disorders?. Biochem Biophys Res Commun, 2010, 391(1): 6-10
16. Salih D A, Brunet A. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr Opin Cell Biol, 2008, 20(2): 126-136
17. Cohen H Y, Miller C, Bitterman K J, et al. Calorie restriction promotes mammalian cell survival by inducing the SIRT1 deacetylase. Science, 2004, 305(5682): 390-392 (Pubitemid 38938153)
18. McBurney M W, Yang X, Jardine K, et al. The mammalian SIR2alpha protein has a role in embryogenesis and gametogenesis. Mol Cell Biol, 2003, 23(1): 38-54 (Pubitemid 36008499)
19. Cheng H L, Mostoslavsky R, Saito S. Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice. Proc Natl Acad Sci USA, 2003, 100(19): 10794-10799 (Pubitemid 37140107)
20. Chen D, Steele A D, Lindquist S, et al. Increase in activity during calorie restriction requires Sirt1. Science, 2005, 310 (5754): 1553-1554
21. Boily G, Seifert E L, Bevilacqua L, et al. SirT1 regulates energy metabolism and response to caloric restriction in mice. PLoS One, 2008, 3(3): e1759
22. Bordone L, Cohen D, Robinson A, et al. SIRT1 transgenic mice show phenotypes resembling calorie restriction. Aging Cell, 2007, 6(6): 759-767 (Pubitemid 350131044)
23. Banks A S, Kon N, Knight C, et al. SirT1 gain of function increases energy efficiency and prevents diabetes in mice. Cell Metab, 2008, 8(4): 333-341
24. Pfluger P T, Herranz D, Velasco-Miguel S, et al. Sirt1 protects against high-fat diet-induced metabolic damage. Proc Natl Acad Sci USA, 2008, 1059(28): 9793-9798 (Pubitemid 352031379)
25. Lagouge M, Argmann C, Gerhart-Hines, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-lalpha. Cell, 2006, 127(6): 1109-1122 (Pubitemid 44894520)
26. Baur J A, Pearson K J, Price N L, et al. Resveratrol improves health and survival of mice on a high-calorie diet. Nature, 2006, 444(7117): 337-342 (Pubitemid 44764104)
27. Lagouge M, Argmann C, Gerhart-Hines Z, et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell, 2006, 127(6): 1109-1122 (Pubitemid 44894520)
28. Feige J N, Lagouge M, Canto C, et al. Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab, 2008, 8(5): 347-358
29. Civitarese A E, Caring S, Heilbronn L K, et al. Calorie restriction increases muscle mitochondrial biogenesis in healthy humans. PloS Med, 2007, 4(3): e76
30. Koubova J, Guarente L. How does calorie restriction work. Genes Dev, 2003, 17(3): 313-321 (Pubitemid 36182188)
31. Anderson R M, Bitterman K J, Wood J G, et al. Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature, 2003, 423(6936): 181-185 (Pubitemid 36569542)
32. Revollo J R, Grimm A A, Imai S. The NAD biosynthesis pathway mediated by nicotinamide phosphoribosy ltransferase regulates Sir2 activity in mammalian cells. J Biol Chem, 2004, 279(49): 50754-50763 (Pubitemid 40017813)
33. Gerland L M, Peyrol S, Lallemand C, et al. Association of increased autophagic inclusions labeled for beta-galactosidase with fibroblastic aging. Exp Gerontol, 2003, 38(8): 887-895 (Pubitemid 36952670)
34. Lee I H, Cao L, Mostoslavsky R, et al. A role for the NAD-dependent deacetylase Sirt1 in the regulation of autophagy. Proc Natl Acad Sci USA, 2008, 105(9): 3374-3379 (Pubitemid 351723560)
35. Geng J, Klionsky D J. The Atg8 and Atg12 ubiquitin-like conjugation systems in macroautophagy. EMBO Rep, 2008, 9(9): 859-864
36. Brunet A, Sweeney L B, Sturgill J F, et al. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science, 2004, 303(5666): 2011-2015 (Pubitemid 38393275)
37. Campisi J, d'Adda di Fagagna F. Cellular senescence: When bad things happen to good cells. Nat Rev Mol Cell Biol, 2007, 8 (9): 729-740 (Pubitemid 47312822)
38. Schmid G, Kramer M P, Maurer M, et al. Cellular and organismal ageing: role of the p53 tumor suppressor protein in the induction of transient and terminal senescence. J Cell Biochem, 2007, 101 (6): 1355-1369 (Pubitemid 47242768)
39. Vaziri H, Dessain S K, Ng Eaton E. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell, 2001, 107(2): 149-159 (Pubitemid 33035942)
40. Tasdemir E, Maiuri M C, Orhon I. p53 represses autophagy in a cell cycle-dependent fashion. Cell Cycle, 2008, 7(19): 3006-3011
41. Tavernakis N, Pasparaki A, Tasdemir E, et al. The effects of p53 on whole organism longevity are mediated by autophagy. Autophage, 2008, 4(7): 870-873
42. Salminen A, Kaarniranta K. SIRT1: regulation of longevity via autophagy. Cell Signal, 2009, 21(9): 1356-1360
43. Lombard D B, Schwer B, Alt F W, et al. SIRT6 in DNA repair, metabolism and ageing. J Intern Med, 2008, 263(2): 128-141
44. Tennen R I, Berber E, Chua K F. Functional dissection of SIRT6: identification of domains that regulate histone deacetylase activity and chromatin localization. Mech Ageing Dev, 2010, 131(3): 185-192
45. Michishita E, McCord R A, Boxer L D, et al. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle, 2009, 8(16): 2664-2666
46. Yang B, Zwaans B M, Eckersdorff M, et al. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle, 2009, 15(8): 2662-2663
47. Kawahara T L, Michishita E, AdlerA S, et al. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal lifespan. Cell, 2009, 136(1): 62-74
48. Kume S, Uzu T, Kashiwagi A, et al. SIRT1, a calorie restriction mimetic, in a new therapeutic approach for type 2 diabetes mellitus and diabetic vascular complications. Endocr Metab Immune Disord Drug Targets, 2010, 10(1): 16-24
49. Lavu S, Boss O, Elliott P J, et al. Sirtuins-novel therapeutic targets to treat age-associated diseases. Nat Rev Drug Discov, 2008, 7(10): 841-853
50. Li X, Zhang S, Blader G, et al. SIRT1 deacetylates and positively regulates the nuclear receptor LXR. Mol Cell, 2007, 28(1): 91-106 (Pubitemid 47531974)
51. Potente M, Ghaeni L, Baldessari D, et al. SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev, 2007, 21(20): 2644-2658 (Pubitemid 47607673)